Wael Rayya
Overview
Explore the profile of Wael Rayya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loch F, Kamphues C, Rieger F, Beyer K, Rayya W, Schineis C, et al.
Int J Surg Pathol
. 2024 Feb;
32(8):1429-1440.
PMID: 38303519
The prognostic role of tumor cells in pancreatic ductal adenocarcinoma (PDAC) of the pancreatic head with direct microscopic infiltration (DMI) or in close proximity (≤1 mm) to the resection margin...
2.
Loch F, Beyer K, Kreis M, Kamphues C, Rayya W, Schineis C, et al.
Eur Radiol
. 2023 Nov;
34(5):3183-3193.
PMID: 37921924
Objectives: Diagnostic performance of imaging for regional lymph node assessment in gastric cancer is still limited, and there is a lack of consensus on radiological evaluation. At the same time,...
3.
Loch F, Kamphues C, Beyer K, Schineis C, Rayya W, Lauscher J, et al.
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36768480
Immune checkpoint therapy (ICT) has shown promising potential in the treatment of multiple solid tumors. However, the role of ICT in pancreatic ductal adenocarcinoma (PDAC) remains limited. Patterns of immune...
4.
Loch F, Klein O, Beyer K, Klauschen F, Schineis C, Lauscher J, et al.
Biology (Basel)
. 2021 Oct;
10(10).
PMID: 34681132
Despite the overall poor prognosis of pancreatic cancer there is heterogeneity in clinical courses of tumors not assessed by conventional risk stratification. This yields the need of additional markers for...